PREVALENCE OF MENSTRUAL MIGRAINE AND THE EFFICACY OF SUMATRIPTAN ADMINISTRATION
Open Access
- 26 January 2024
- journal article
- Published by Universitas Airlangga in Jurnal Berkala Epidemiologi
- Vol. 12 (1) , 62-70
Abstract
Background: Menstrual migraine is a primary headache that often attacks women of reproductive age. This type of migraine has high severity and is resistant to treatment. Therefore, an effective treatment is needed to treat this menstrual migraine. Sumatriptan has been shown to have a better effect as an acute treatment for menstrual migraine patients. Purpose: This study aims to determine the prevalence and effectiveness of sumatriptan as a therapy for menstrual migraine. Methods: This research is based on a literature review following predetermined inclusion criteria. First, a literature search was carried out adhering to the PRISMA flow in 4 databases: Pubmed, Science Direct, ProQuest, and ClinicalTrial.co. Results: Based on keywords, 267 studies were found in the literature search. However, only three studies covering 845 participants met the predetermined inclusion criteria. The average age of menstrual migraine patients in the three studies was 37 years. These three studies of sumatriptan revealed a significant effect in providing a pain-free response in menstrual migraine patients. These three studies also showed that sumatriptan 100 mg has a higher level of effectiveness in providing a pain-free response in menstrual migraine sufferers and was preferably given during mild attacks. Conclusion: These three studies indicate that typically, women who suffer from menstrual migraines are of reproductive age. Additionally, this study shows that using sumatriptan as an acute therapy significantly helps provide a pain-free response in menstrual migraine patients.Keywords
This publication has 27 references indexed in Scilit:
- Population-Based Characterization of Menstrual Migraine and Proposed Diagnostic CriteriaJAMA Network Open, 2023
- Clinical differences between menstrual migraine and nonmenstrual migraine: a systematic review and meta-analysis of observational studiesJournal of Neurology, 2022
- Evaluation of sex differences in the pharmacokinetics of oral sumatriptan in healthy Korean subjects using population pharmacokinetic modelingBiopharmaceutics & Drug Disposition, 2022
- Effects of the Menstrual Cycle on Neurological DisordersCurrent Neurology and Neuroscience Reports, 2021
- Menstrual Migraine Among Spanish University StudentsJournal of Pediatric Nursing, 2021
- Management of Menstrual MigraineCurrent Neurology and Neuroscience Reports, 2020
- Proteomic serum profile in menstrual-related and post menopause migraineJournal of Pharmaceutical and Biomedical Analysis, 2020
- Targeting the 5-HT1B/1D and 5-HT1F receptors for acute migraine treatment2020
- Migraine Throughout the Female Reproductive Life CycleMayo Clinic Proceedings, 2018
- Managing migraine headaches experienced by patients who self–report with menstrually related migraine: a prospective, placebo–controlled study with oral sumatriptanThe Journal of Headache and Pain, 2005